Can lifestyle choices after a stroke extend life and prevent a second one?

NCT ID NCT03962127

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study follows 800 adults who have had their first ischemic stroke in Central Norway for up to 10 years. Researchers will track how physical activity, medication use, and control of blood pressure and cholesterol affect the risk of death, another stroke, or severe disability. The goal is to find ways to improve stroke care and help survivors live longer with a better quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could reveal which lifestyle factors and medication targets most improve long-term outcomes after a first stroke, potentially guiding more effective rehabilitation and prevention strategies.
What could go wrong
As an observational study, it cannot prove cause and effect. Results may be influenced by unmeasured factors, and the findings might not apply to stroke patients outside Central Norway.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN ISCHEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kristiansund Sykehus

    Kristiansund, Norway

  • Levanger Sykehus

    Levanger, Norway

  • Molde Sykehus

    Molde, Norway

  • Namsos Sykehus

    Namsos, Norway

  • Orkdal Sykehus

    Orkanger, Norway

  • St Olavs Hospital

    Trondheim, Norway

  • Volda Sykehus

    Volda, Norway

  • Ålesund Sykehus

    Ålesund, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.